Lose 23% of your body weight in 1 year according to research
Ships free to your door in 2-7 days with tracking
FDA-approved medications for weight loss and diabetes
*Eli Lilly’s SURMOUNT-1 study revealed that tirzepatide caused participants to experience significant weight loss, with an average reduction of 22.9% in body weight at the highest dose and reduced risk of developing type 2 diabetes by 94% in adults with pre-diabetes and obesity/overweight.
Common Questions About Mounjaro®
Learn more about Mounjaro®, how it works and how to get approved.
What is Mounjaro®?
Mounjaro® is the brand-name of the generic medication Tirzepatide. Mounjaro® is approved for managing specific symptoms and risks associated with Type 2 Diabetes. Administered through a pre-filled single-dose pen, Mounjaro® functions similarly to a naturally occurring hormone in the body that regulates blood sugar.
How does Wegovy® work?
Mounjaro®, akin to other GLP-1 medications like Ozempic®, operates as a glucagon-like peptide 1 receptor agonist. However, it stands out as a dual-action GLP-1 and GIP (glucose-dependent insulinotropic polypeptide) medication. By mimicking the actions of both hormones, Mounjaro® regulates metabolism, inducing a sense of fullness and controlling hunger. Alongside a proper diet and exercise regimen, Mounjaro® proves very effective in supporting weight loss.